Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    "Urachal cancer"
Show Display Options
RSS Create an RSS feed from your search for:
"Urachal cancer"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Active, not recruiting Fluorouracil, Leucovorin, Gemcitabine, and Cisplatin in Treating Patients With Metastatic or Unresectable Adenocarcinoma of the Urothelium or Urachal Remnant
Conditions: Bladder Cancer;   Urethral Cancer;   Urachal Cancer
Interventions: Drug: 5-Fluorouracil (5-FU);   Drug: Leucovorin;   Drug: Cisplatin;   Drug: Gemcitabine

Indicates status has not been verified in more than two years